- Home
- Primary Care
- Lecanemab in Early Alzheimer’s Disease (AD): Clinical Evidence & Synopsis

4w3 min read
Medical Article
Introduction: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and impaired daily functioning (1). This debilitating neurodegenerative disorder affects 50 million people worldwide and represents a significant public health challenge, with a growing prevalence due to aging populati

Lecanemab in Early Alzheimer’s Disease (AD): Clinical Evidence & Synopsis
974 Reached6 Comments
Similar Content

Woman presented with Fever of Unknown Origin
7718 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes

Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes

Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes